Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Gum Tech name change

This article was originally published in The Tan Sheet

Executive Summary

Company will seek shareholder approval at June 18 annual meeting to change corporate name to Matrixx Initiatives. NASDAQ ticker symbol would change to MTXX, firm says April 9. "Matrixx means a 'source or structure from which something else originates, develops or takes form,' which we feel represents well the...growth initiatives we will continue to pursue," Zicam maker says. Firm additionally will seek approval to change state of incorporation from Utah to Delaware. Also, Julie Johannsen named to newly created position of marketing director; she most recently served as a senior brand manager at Dial Corp.'s personal cleansing division...

You may also be interested in...



Matrixx Zicam Swabs, Other Extensions Slated For September

Matrixx Initiatives, formerly Gum Tech International, is introducing a novel delivery vehicle to the OTC cough/cold remedy market - Zicam Cold Remedy Swabs

Cosmetic And Personal Care Trademark Review 13 April, 2021

Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.

Mayo Clinic Launches Two Companies To Support New Remote Monitoring Initiative

The Minnesota-based health care system announced the formation of Anumana Inc. to commercialize artificial intelligence-enabled algorithms and Lucem Health to curate data collected from remote monitoring devices.

Topics

UsernamePublicRestriction

Register

PS093879

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel